ORASURE TECHNOLOGIES, INC Contract Liability (Deferred Revenue)
ORASURE TECHNOLOGIES, INC (OSUR) had Contract Liability (Deferred Revenue) of $851.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:ContractWithCustomerLiabilityCurrent · last filed 2026-08-07
- 2026-06-30: Contract with Customer, Liability, Current $851.00K.
- 2026-03-31: Contract with Customer, Liability, Current $872.00K.
- 2025-12-31: Contract with Customer, Liability, Current $1.52M.
- 2025-09-30: Contract with Customer, Liability, Current $1.88M.
| Period end | Contract with Customer, Liability, Current | Contract with Customer, Liability, Current as first filed |
|---|---|---|
| 2026-06-30 | $851.00K 10-Q · filed 2026-08-07 | |
| 2026-03-31 | $872.00K 10-Q · filed 2026-05-08 | |
| 2025-12-31 | $1.52M 10-Q · filed 2026-08-07 | |
| 2025-09-30 | $1.88M 10-Q · filed 2025-11-05 | |
| 2025-06-30 | $2.45M 10-Q · filed 2025-08-06 | |
| 2025-03-31 | $2.51M 10-Q · filed 2025-05-07 | |
| 2024-12-31 | $2.96M 10-K · filed 2026-03-09 | $3.00M 10-K · filed 2025-03-07 |
| 2024-09-30 | $1.62M 10-Q · filed 2024-11-06 | |
| 2024-06-30 | $1.45M 10-Q · filed 2024-08-06 | |
| 2024-03-31 | $1.60M 10-Q · filed 2024-05-09 | |
| 2023-12-31 | $1.56M 10-K · filed 2026-03-09 | $1.20M 10-K · filed 2024-03-11 |
| 2023-09-30 | $1.82M 10-Q · filed 2023-11-08 | |
| 2023-06-30 | $1.84M 10-Q · filed 2023-08-04 | |
| 2023-03-31 | $1.99M 10-Q · filed 2023-05-10 | |
| 2022-12-31 | $1.50M 10-K · filed 2024-03-11 | $2.27M 10-K · filed 2023-03-03 |
| 2022-09-30 | $2.54M 10-Q · filed 2022-11-08 | |
| 2022-06-30 | $2.66M 10-Q · filed 2022-08-09 | |
| 2022-03-31 | $2.91M 10-Q · filed 2022-05-10 | |
| 2021-12-31 | $2.94M 10-K · filed 2023-03-03 | |
| 2021-09-30 | $3.49M 10-Q · filed 2021-11-04 | |
| 2021-06-30 | $4.24M 10-Q · filed 2021-08-05 | |
| 2021-03-31 | $4.58M 10-Q · filed 2021-05-06 | |
| 2020-12-31 | $4.81M 10-K · filed 2022-03-01 | |
| 2020-09-30 | $5.31M 10-Q · filed 2020-11-05 | |
| 2020-06-30 | $4.92M 10-Q · filed 2020-08-06 | |
| 2020-03-31 | $4.31M 10-Q · filed 2020-05-11 | |
| 2019-12-31 | $3.71M 10-K · filed 2021-03-01 | |
| 2019-09-30 | $3.94M 10-Q · filed 2019-11-08 | |
| 2019-06-30 | $3.91M 10-Q · filed 2019-08-07 | |
| 2019-03-31 | $4.23M 10-Q · filed 2019-05-09 | |
| 2018-12-31 | $3.52M 10-K · filed 2020-03-02 | |
| 2018-09-30 | $3.11M 10-Q · filed 2018-11-08 | |
| 2018-06-30 | $1.62M 10-Q · filed 2018-08-09 | |
| 2017-12-31 | $1.31M 10-K · filed 2020-03-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |